An enhanced thirteen-week bioassay as an alternative for screening for carcinogenesis factors
- PMID: 20593920
An enhanced thirteen-week bioassay as an alternative for screening for carcinogenesis factors
Abstract
Utilizing basic concepts of chemical carcinogenesis and the human relevance framework based on mode of action analysis of animal carcinogens, an alternative is proposed for the two-year bioassay for screening chemicals for potential carcinogenic risk in humans. This model includes short-term screening of chemicals for DNA reactivity, immunosuppressive and, estrogenic activity, and potential increased cell proliferation. Follow-up studies can provide detailed information with regard to dose response and mode of action, with a detailed evaluation of potential relevance to humans. It is no longer appropriate to continue performing two year rodent bioassays.
Similar articles
-
Evolution of the uses of rats and mice for assessing carcinogenic risk from chemicals in humans.Asian Pac J Cancer Prev. 2010;11(1):18. Asian Pac J Cancer Prev. 2010. PMID: 20593921
-
An enhanced 13-week bioassay: an alternative to the 2-year bioassay to screen for human carcinogenesis.Exp Toxicol Pathol. 2010 Sep;62(5):497-502. doi: 10.1016/j.etp.2009.06.011. Epub 2009 Jul 17. Exp Toxicol Pathol. 2010. PMID: 19616417
-
Human carcinogenic risk evaluation: an alternative approach to the two-year rodent bioassay.Toxicol Sci. 2004 Aug;80(2):225-9. doi: 10.1093/toxsci/kfh159. Epub 2004 May 5. Toxicol Sci. 2004. PMID: 15129023 Review.
-
Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary.Toxicol Pathol. 2010 Apr;38(3):487-501. doi: 10.1177/0192623310363813. Epub 2010 Mar 9. Toxicol Pathol. 2010. PMID: 20215581
-
Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.IARC Sci Publ. 1999;(146):251-72. IARC Sci Publ. 1999. PMID: 10353390 Review. No abstract available.
Cited by
-
Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.Crit Rev Toxicol. 2013 Mar;43(3):244-74. doi: 10.3109/10408444.2013.768596. Crit Rev Toxicol. 2013. PMID: 23445218 Free PMC article. Review.
-
A chronic oral reference dose for hexavalent chromium-induced intestinal cancer.J Appl Toxicol. 2014 May;34(5):525-36. doi: 10.1002/jat.2907. Epub 2013 Aug 14. J Appl Toxicol. 2014. PMID: 23943231 Free PMC article.
-
Synchrotron-based imaging of chromium and γ-H2AX immunostaining in the duodenum following repeated exposure to Cr(VI) in drinking water.Toxicol Sci. 2015 Jan;143(1):16-25. doi: 10.1093/toxsci/kfu206. Epub 2014 Oct 28. Toxicol Sci. 2015. PMID: 25352572 Free PMC article.
-
Assessment of Cr(VI)-induced cytotoxicity and genotoxicity using high content analysis.PLoS One. 2012;7(8):e42720. doi: 10.1371/journal.pone.0042720. Epub 2012 Aug 8. PLoS One. 2012. PMID: 22905163 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources